Devin W. Smith - 12 Jan 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: General Counsel
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Devin W. Smith
Issuer symbol: IOBT
Transactions as of: 12 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 13 Jan 2023, 15:49:09 UTC
Previous filing: 13 Jan 2023
Next filing: 09 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOBT	Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	12 Jan 2023	Common Stock	150,000	$2.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Content

One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.